Published in Vaccine Weekly, December 4th, 2002
M.H. Mohajeri and colleagues, University of Zurich, conducted a study in transgenic mice to "characterize the effects of the familial Alzheimer's disease-causing Swedish mutations of amyloid precursor protein (SwAPP) on the vulnerability of central nervous system neurons."
They caused the SwAPP-expressing mice to have epileptic seizures.
"The transgene expression did not change the seizure threshold, but consistently more neurons degenerated in brains of SwAPP mice...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2002-12-04)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.